HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests 5-Day radiation vs. Month-Long treatment for skin cancer
Disease control Recruiting nowThis study tests if a shorter, more precise radiation treatment (5 sessions) works as well as the standard longer treatment (20-30 sessions) for skin cancer that has spread to the lymph nodes in the neck. About 90 adults who have had surgery for this type of skin cancer will take…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New shot targets tough cancers: early trial seeks 150 patients
Disease control Recruiting nowThis early-stage study tests a new drug called SH009 in about 150 people with advanced solid tumors (like liver, lung, or breast cancer) that have not responded to standard treatments. The main goal is to see if the drug is safe and can shrink tumors. Researchers will also measur…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New drug cocktail shows promise in shrinking head and neck tumors before surgery
Disease control Recruiting nowThis study tests a new combination of drugs given before surgery for people with advanced head and neck cancer. The goal is to see if this approach can shrink tumors more effectively, potentially making surgery easier or even possible for some patients. About 76 adults with stage…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New combo therapy aims to shrink head and neck tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug called VS-101 to standard chemoradiotherapy helps control head and neck cancer better than standard treatment alone. About 30 adults with squamous cell carcinoma of the mouth, throat, or voice box will take part. The main goal …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated May 05, 2026 11:53 UTC